Aspirin

As the non-steroidal anti-inflammatory drug of antipyretic and analgesic category with the longest application history in the world, aspirin irreversibly inhibits the activity of cyclooxygenase and reduces the production of prostaglandins and thromboxanes, thus realizing multiple effects of anti-inflammation, analgesia, antipyretic and anti-platelet aggregation. At the clinical level, low-dose aspirin is widely used for thrombosis prevention in high-risk populations of cardiovascular and cerebrovascular diseases to reduce the risk of myocardial infarction and stroke; conventional-dose aspirin can relieve mild to moderate pain such as headache, toothache and arthralgia, and can also be used for antipyretic treatment of febrile diseases such as cold and influenza, with applicable populations covering patients under chronic disease management and people using drugs for symptomatic treatment of common symptoms.

At present, the global market size of aspirin active pharmaceutical ingredient is stable at around USD 1.2 billion, with the annual compound growth rate maintained at 2.3%, and the demand side shows prominent rigid characteristics. China is the core supplier of aspirin active pharmaceutical ingredient in the world, with its production capacity accounting for more than 70% of the global total production capacity. Leading enterprises have remarkable advantages in large-scale production. The preparation side has long passed the patent period, and the generic drug substitution rate is close to 100%. After the implementation of domestic centralized procurement, the terminal price tends to be stable, and the concentration of upstream demand for active pharmaceutical ingredients has further increased.

CATO can provide a full set of impurity reference standards for aspirin active pharmaceutical ingredient. All products meet the compliance requirements of multiple regulatory systems such as Chinese Pharmacopoeia and FDA. The full-range in-stock inventory can quickly respond to the delivery demands of pharmaceutical enterprises in all links of R&D and quality control, helping customers simplify the supply chain management process and reduce compliance risks.